Literature DB >> 26893006

Dyslipidemia in Special Ethnic Populations.

Jia Pu1, Robert Romanelli2, Beinan Zhao2, Kristen M J Azar2, Katherine G Hastings3, Vani Nimbal2, Stephen P Fortmann4, Latha P Palaniappan3.   

Abstract

This article reviews racial/ethnic differences in dyslipidemia-prevalence of dyslipidemia, its relation to coronary heart disease (CHD) and stroke mortality rates, response to lipid-lowering agents, and lifestyle modification. Asian Indians, Filipinos, and Hispanics are at higher risk for dyslipidemia, which is consistent with the higher CHD mortality rates in these groups. Statins may have greater efficacy for Asians, but the data are mixed. Lifestyle modifications are recommended. Culturally-tailored prevention and intervention should be provided to the minority populations with elevated risk for dyslipidemia and considerably more research is needed to determine the best approaches to helping specific subgroups.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dyslipidemia; Lifestyle modification; Mortality; Prevalence; Racial/ethnic differences; Treatment

Year:  2016        PMID: 26893006      PMCID: PMC7251984          DOI: 10.1016/j.ecl.2015.09.013

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  69 in total

1.  Is there progress toward eliminating racial/ethnic disparities in the leading causes of death?

Authors:  Kenneth G Keppel; Jeffrey N Pearcy; Melonie P Heron
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

2.  Meeting of the International Working Group on Coronary Artery Disease in South Asians. 24 March 1996, Orlando, Florida, USA.

Authors:  E A Enas; S Yusuf; J Mehta
Journal:  Indian Heart J       Date:  1996 Nov-Dec

3.  Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.

Authors:  Edmund Lee; Stephen Ryan; Bruce Birmingham; Julie Zalikowski; Ruth March; Helen Ambrose; Rachael Moore; Caroline Lee; Yusong Chen; Dennis Schneck
Journal:  Clin Pharmacol Ther       Date:  2005-10       Impact factor: 6.875

Review 4.  Diabetes, insulin resistance and vascular disease among Indian Asians and Europeans.

Authors:  John C Chambers; Jaspal S Kooner
Journal:  Semin Vasc Med       Date:  2002-05

5.  Efficacy and safety of simvastatin in Asian and non-Asian coronary heart disease patients: a comparison of the GOALLS and STATT studies.

Authors:  Dante Morales; Namsik Chung; Jun-Ren Zhu; Somkiat Sangwatanaroj; Wei-Hsien Yin; Kathy Lee; Michael J Davies; Arvind Shah; Tom Loeys; David Bilheimer
Journal:  Curr Med Res Opin       Date:  2004-08       Impact factor: 2.580

6.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

7.  Racial/ethnic differences in dyslipidemia patterns.

Authors:  Ariel T H Frank; Beinan Zhao; Powell O Jose; Kristen M J Azar; Stephen P Fortmann; Latha P Palaniappan
Journal:  Circulation       Date:  2013-11-05       Impact factor: 29.690

8.  Heart disease prevention among Chinese immigrants.

Authors:  Vicky M Taylor; Yutaka Yasui; Shin-Ping Tu; Marian L Neuhouser; Lin Li; Erica Woodall; Elizabeth Acorda; Swee May Cripe; T Gregory Hislop
Journal:  J Community Health       Date:  2007-10

9.  Statin effects on LDL and HDL cholesterol in South Asian and white populations.

Authors:  Milan Gupta; Manoela F B Braga; Hwee Teoh; Michelle Tsigoulis; Subodh Verma
Journal:  J Clin Pharmacol       Date:  2009-04-27       Impact factor: 3.126

10.  Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.

Authors:  Chau-Chung Wu; Rody Sy; Vichai Tanphaichitr; Arthur Tan Teow Hin; Slamet Suyono; Yuan-Teh Lee
Journal:  J Formos Med Assoc       Date:  2002-07       Impact factor: 3.282

View more
  5 in total

1.  The associations between early pregnancy lipid profiles and pregnancy outcomes.

Authors:  C Wang; W Zhu; Y Wei; R Su; H Feng; E Hadar; M Hod; H Yang
Journal:  J Perinatol       Date:  2016-10-27       Impact factor: 2.521

2.  Biopsychosocial Health Outcomes and Experienced Intersectional Stigma in a Mixed HIV Serostatus Longitudinal Cohort of Aging Sexual Minority Men, United States, 2008‒2019.

Authors:  M Reuel Friedman; Qimin Liu; Steven Meanley; Sabina A Haberlen; Andre L Brown; Bulent Turan; Janet M Turan; Mark Brennan-Ing; Valentina Stosor; Matthew J Mimiaga; Deanna Ware; James E Egan; Michael W Plankey
Journal:  Am J Public Health       Date:  2022-06       Impact factor: 11.561

Review 3.  Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices.

Authors:  Nuntakorn Thongtang; Renan Sukmawan; Elmer Jasper B Llanes; Zhen-Vin Lee
Journal:  Prev Med Rep       Date:  2022-05-05

4.  Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records.

Authors:  Fatima Rodriguez; Sukyung Chung; Manuel R Blum; Adrien Coulet; Sanjay Basu; Latha P Palaniappan
Journal:  J Am Heart Assoc       Date:  2019-07-11       Impact factor: 6.106

5.  Years of Potential Life Lost Because of Cardiovascular Disease in Asian-American Subgroups, 2003-2012.

Authors:  Divya G Iyer; Nilay S Shah; Katherine G Hastings; Jiaqi Hu; Fatima Rodriguez; Derek B Boothroyd; Aruna V Krishnan; Titilola Falasinnu; Latha Palaniappan
Journal:  J Am Heart Assoc       Date:  2019-04-02       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.